• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制 AXL 通过降低糖酵解增强人卵巢癌细胞对顺铂的化疗敏感性。

Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.

机构信息

Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.

Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410008, China.

出版信息

Acta Pharmacol Sin. 2021 Jul;42(7):1180-1189. doi: 10.1038/s41401-020-00546-8. Epub 2020 Nov 4.

DOI:10.1038/s41401-020-00546-8
PMID:33149145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8209001/
Abstract

Anexelekto (AXL), a member of the TYRO3-AXL-MER (TAM) family of receptor tyrosine kinases (RTK), is overexpressed in varieties of tumor tissues and promotes tumor development by regulating cell proliferation, migration and invasion. In this study, we investigated the role of AXL in regulating glycolysis in human ovarian cancer (OvCa) cells. We showed that the expression of AXL mRNA and protein was significantly higher in OvCa tissue than that in normal ovarian epithelial tissue. In human OvCa cell lines suppression of AXL significantly inhibited cell proliferation, and increased the sensitivity of OvCa cells to cisplatin, which also proved by nude mice tumor formation experiment. KEGG analysis showed that AXL was significantly enriched in the glycolysis pathways of cancer. Changes in AXL expression in OvCa cells affect tumor glycolysis. We demonstrated that the promotion effect of AXL on glycolysis was mediated by phosphorylating the M2 isoform of pyruvate kinase (PKM2) at Y105. AXL expression was significantly higher in cisplatin-resistant OvCa cells A2780/DDP compared with the parental A2780 cells. Inhibition of AXL decreased the level of glycolysis in A2780/DDP cells, and increased the cytotoxicity of cisplatin against A2780/DDP cells, suggesting that AXL-mediated glycolysis was associated with cisplatin resistance in OvCa. In conclusion, this study demonstrates for the first time that AXL is involved in the regulation of the Warburg effect. Our results not only highlight the clinical value of targeting AXL, but also provide theoretical basis for the combination of AXL inhibitor and cisplatin in the treatment of OvCa.

摘要

AXL(AXL)是酪氨酸激酶受体(RTK)TYRO3-AXL-MER(TAM)家族的成员,在各种肿瘤组织中过表达,并通过调节细胞增殖、迁移和侵袭来促进肿瘤的发展。在这项研究中,我们研究了 AXL 在调节人卵巢癌(OvCa)细胞糖酵解中的作用。我们发现 AXL mRNA 和蛋白的表达在 OvCa 组织中明显高于正常卵巢上皮组织。在人 OvCa 细胞系中,AXL 的抑制显著抑制了细胞增殖,并增加了 OvCa 细胞对顺铂的敏感性,这也通过裸鼠肿瘤形成实验得到了证明。KEGG 分析表明,AXL 在癌症的糖酵解途径中显著富集。OvCa 细胞中 AXL 表达的变化影响肿瘤糖酵解。我们证明了 AXL 对糖酵解的促进作用是通过使丙酮酸激酶(PKM2)的 M2 同工型 Y105 磷酸化来介导的。与亲本 A2780 细胞相比,顺铂耐药 OvCa 细胞 A2780/DDP 中 AXL 的表达明显更高。AXL 的抑制降低了 A2780/DDP 细胞中的糖酵解水平,并增加了顺铂对 A2780/DDP 细胞的细胞毒性,表明 AXL 介导的糖酵解与 OvCa 中的顺铂耐药有关。总之,这项研究首次证明 AXL 参与调节瓦伯格效应。我们的研究结果不仅突出了靶向 AXL 的临床价值,还为 AXL 抑制剂与顺铂联合治疗 OvCa 提供了理论基础。

相似文献

1
Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.抑制 AXL 通过降低糖酵解增强人卵巢癌细胞对顺铂的化疗敏感性。
Acta Pharmacol Sin. 2021 Jul;42(7):1180-1189. doi: 10.1038/s41401-020-00546-8. Epub 2020 Nov 4.
2
R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.R428 是一种选择性的 Axl 激酶小分子抑制剂,可阻止转移性乳腺癌模型中的肿瘤扩散并延长生存期。
Cancer Res. 2010 Feb 15;70(4):1544-54. doi: 10.1158/0008-5472.CAN-09-2997. Epub 2010 Feb 9.
3
Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer.受体酪氨酸激酶 AXL 的治疗性抑制可提高卵巢癌对铂类和紫杉烷类药物的敏感性。
Mol Cancer Ther. 2019 Feb;18(2):389-398. doi: 10.1158/1535-7163.MCT-18-0537. Epub 2018 Nov 26.
4
The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer.GAS6-AXL信号网络是卵巢癌间充质(Mes)分子亚型特异性治疗靶点。
Sci Signal. 2016 Oct 4;9(448):ra97. doi: 10.1126/scisignal.aaf8175.
5
Metformin targets Axl and Tyro3 receptor tyrosine kinases to inhibit cell proliferation and overcome chemoresistance in ovarian cancer cells.二甲双胍靶向Axl和Tyro3受体酪氨酸激酶以抑制卵巢癌细胞的增殖并克服化疗耐药性。
Int J Oncol. 2015 Jul;47(1):353-60. doi: 10.3892/ijo.2015.3004. Epub 2015 May 12.
6
Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma.受体酪氨酸激酶 AXL 的调控及其在胶质母细胞瘤治疗抵抗中的作用。
Int J Mol Sci. 2022 Jan 17;23(2):982. doi: 10.3390/ijms23020982.
7
Targeting AXL overcomes resistance to docetaxel therapy in advanced prostate cancer.靶向AXL可克服晚期前列腺癌对多西他赛治疗的耐药性。
Oncotarget. 2017 Jun 20;8(25):41064-41077. doi: 10.18632/oncotarget.17026.
8
Transcriptional upregulation of c-MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma.AXL 转录上调 c-MYC 赋予食管腺癌对表柔比星的耐药性。
Mol Oncol. 2018 Dec;12(12):2191-2208. doi: 10.1002/1878-0261.12395. Epub 2018 Nov 5.
9
Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.抑制受体酪氨酸激酶 AXL 可恢复紫杉醇在子宫浆液性癌中的化疗敏感性。
Mol Cancer Ther. 2017 Dec;16(12):2881-2891. doi: 10.1158/1535-7163.MCT-17-0587. Epub 2017 Sep 13.
10
Axl Inhibitor R428 Enhances TRAIL-Mediated Apoptosis Through Downregulation of c-FLIP and Survivin Expression in Renal Carcinoma.Axl 抑制剂 R428 通过下调肾癌细胞中 c-FLIP 和 Survivin 的表达增强 TRAIL 介导的细胞凋亡。
Int J Mol Sci. 2019 Jul 2;20(13):3253. doi: 10.3390/ijms20133253.

引用本文的文献

1
Signaling networks and MiRNA crosstalk in ovarian cancer chemoresistance.卵巢癌化疗耐药中的信号网络与微小RNA相互作用
J Ovarian Res. 2025 Aug 14;18(1):185. doi: 10.1186/s13048-025-01770-8.
2
The Role of Axl Inhibition and Immune Checkpoint Blockade in Non-small Cell Lung Cancer: Current Understanding and Treatment Strategies.Axl抑制和免疫检查点阻断在非小细胞肺癌中的作用:当前认识与治疗策略
Cancer Diagn Progn. 2025 Jun 30;5(4):417-428. doi: 10.21873/cdp.10455. eCollection 2025 Jul-Aug.
3
Pyruvate Kinase M1/2 Proteoformics for Accurate Insights into Energy Metabolism Abnormity to Promote the Overall Management of Ovarian Cancer Towards Predictive, Preventive, and Personalized Medicine Approaches.丙酮酸激酶M1/2蛋白质组学,用于准确洞察能量代谢异常,以促进卵巢癌的整体管理,迈向预测性、预防性和个性化医学方法。
Metabolites. 2025 Mar 16;15(3):203. doi: 10.3390/metabo15030203.
4
AXL signaling in cancer: from molecular insights to targeted therapies.癌症中的AXL信号传导:从分子洞察到靶向治疗。
Signal Transduct Target Ther. 2025 Feb 10;10(1):37. doi: 10.1038/s41392-024-02121-7.
5
AXL: shapers of tumor progression and immunosuppressive microenvironments.AXL:肿瘤进展和免疫抑制微环境的塑造者
Mol Cancer. 2025 Jan 11;24(1):11. doi: 10.1186/s12943-024-02210-9.
6
Application of single cell sequencing technology in ovarian cancer research (review).单细胞测序技术在卵巢癌研究中的应用(综述)。
Funct Integr Genomics. 2024 Aug 28;24(5):144. doi: 10.1007/s10142-024-01432-w.
7
Glucose metabolism reprogramming in gynecologic malignant tumors.妇科恶性肿瘤中的葡萄糖代谢重编程
J Cancer. 2024 Mar 17;15(9):2627-2645. doi: 10.7150/jca.91131. eCollection 2024.
8
Identification of a novel DNA repair inhibitor using an in silico driven approach shows effective combinatorial activity with genotoxic agents against multidrug-resistant Escherichia coli.利用计算机驱动的方法鉴定新型 DNA 修复抑制剂,显示其与遗传毒性药物联合使用对多药耐药大肠杆菌具有有效的组合活性。
Protein Sci. 2024 Apr;33(4):e4948. doi: 10.1002/pro.4948.
9
Research progress on the mechanism of glycolysis in ovarian cancer.卵巢癌糖酵解机制的研究进展。
Front Immunol. 2023 Nov 28;14:1284853. doi: 10.3389/fimmu.2023.1284853. eCollection 2023.
10
Isoalantolactone Suppresses Glycolysis and Resensitizes Cisplatin-Based Chemotherapy in Cisplatin-Resistant Ovarian Cancer Cells.异土木香内酯抑制顺铂耐药卵巢癌细胞的糖酵解并使基于顺铂的化疗重新敏感化。
Int J Mol Sci. 2023 Aug 3;24(15):12397. doi: 10.3390/ijms241512397.

本文引用的文献

1
AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications.AXL 受体酪氨酸激酶作为一种有前途的抗癌方法:功能、分子机制和临床应用。
Mol Cancer. 2019 Nov 4;18(1):153. doi: 10.1186/s12943-019-1090-3.
2
Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment.靶向 TAM 受体(TYRO3、AXL 和 MERTK):肿瘤微环境中巨噬细胞的作用。
Mol Cancer. 2019 May 14;18(1):94. doi: 10.1186/s12943-019-1022-2.
3
ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients.ROCplot.org:利用 3104 名乳腺癌患者的转录组数据验证化疗/激素治疗/抗 HER2 治疗的预测生物标志物。
Int J Cancer. 2019 Dec 1;145(11):3140-3151. doi: 10.1002/ijc.32369. Epub 2019 May 7.
4
Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer.受体酪氨酸激酶 AXL 的治疗性抑制可提高卵巢癌对铂类和紫杉烷类药物的敏感性。
Mol Cancer Ther. 2019 Feb;18(2):389-398. doi: 10.1158/1535-7163.MCT-18-0537. Epub 2018 Nov 26.
5
Tyrosine Kinase Signaling in Cancer Metabolism: PKM2 Paradox in the Warburg Effect.癌症代谢中的酪氨酸激酶信号传导:瓦伯格效应中的丙酮酸激酶M2悖论
Front Cell Dev Biol. 2018 Jul 24;6:79. doi: 10.3389/fcell.2018.00079. eCollection 2018.
6
Acetylation accumulates PFKFB3 in cytoplasm to promote glycolysis and protects cells from cisplatin-induced apoptosis.乙酰化作用将 PFKFB3 积累在细胞质中,以促进糖酵解,并保护细胞免受顺铂诱导的细胞凋亡。
Nat Commun. 2018 Feb 6;9(1):508. doi: 10.1038/s41467-018-02950-5.
7
Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer.丙酮酸激酶M2是卵巢癌预后不良的标志物及治疗靶点。
PLoS One. 2017 Jul 28;12(7):e0182166. doi: 10.1371/journal.pone.0182166. eCollection 2017.
8
TAM Receptor Tyrosine Kinases in Cancer Drug Resistance.TAM 受体酪氨酸激酶在癌症耐药中的作用。
Cancer Res. 2017 Jun 1;77(11):2775-2778. doi: 10.1158/0008-5472.CAN-16-2675. Epub 2017 May 19.
9
Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway.糖代谢适应性通过AKT-mTOR/c-Myc信号通路介导耐药K562/ADM白血病细胞对阿霉素的不敏感性。
Mol Med Rep. 2017 Apr;15(4):1869-1876. doi: 10.3892/mmr.2017.6189. Epub 2017 Feb 10.
10
Computational and Immunohistochemical Analyses Highlight AXL as a Potential Prognostic Marker for Ovarian Cancer Patients.计算分析和免疫组织化学分析表明AXL是卵巢癌患者潜在的预后标志物。
Anticancer Res. 2016 Aug;36(8):4155-63.